MedTrace Logo

Assessment of Lung Inflammation With FDG PET/CT in COVID-19

NCT04441489 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 13

Last updated 2020-06-22

No results posted yet for this study

Summary

The aim of the study was to assess the inflammatory status at the presumed peak of the inflammatory phase in non-critically ill patients requiring admission for COVID-19. Patients admitted with COVID-19 from March 27th to May 3rd, 2020 were prospectively enrolled. All patients had an initial chest CT-scan for diagnosis on admission and a second chest CT-scan for follow-up concomitant with a FDG PET/CT between day 6 and day 14 after the onset of symptoms.

Conditions

Sponsors & Collaborators

  • Centre Hospitalier Princesse Grace

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-27
Primary Completion
2020-05-03
Completion
2020-05-27

Countries

  • Monaco

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04441489 on ClinicalTrials.gov